CORSAIR CAPITAL MANAGEMENT, L.P.
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1276470
NEW YORK, NY
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,539,200
+$310,700 QoQ
Shares Held
370,000
+5.7% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#68
of 292 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CORSAIR CAPITAL MANAGEMENT, L.P. holds $1,622,400 across 2 Biotechnology names. IOVA ranks #1 (94.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
This page
|
370,000 | $1,539,200 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
80,000 | $83,200 |
All Filings in IOVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,539,200 | 370,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,228,500 | 350,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $819,000 | 300,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||